Zeliha Aslı Demir, Hülya Yiğit Özay, Eda Balcı, Melike Kaya Bahçecitapar

Koroner Arter Cerrahisi Geçiren Hastalarda İntravenöz Anestezi ve İnhalasyon Anestezisinin Kırmızı Hücre Dağılım Genişliği ve Ortalama Platelet Volümü Üzerine Etkileri

Amaç: Koroner arter cerrahisi geçiren hastalarda, midazolam bazlı intravenöz anestezi (TIVA) ile sevofluran bazlı inhalasyon anestezisinin (SEVO) postoperatif hematolojik parametreler üzerine etkilerini incelemeyi amaçladık. Yöntem: Çalışmamıza dahil edilen 100 hasta anestezi yönetimlerine göre iki gruba ayrıldı: Tüm hastaların anestezi indüksiyonları 10 μg kg-1 fentanil, 0.15 mg kg-1 midazolam ve 0.8 mg kg-1 roküronyum ile gerçekleştirildi. TIVA grubu hastaların anestezi idamesi total intravenöz anestezi ile gerçekleştirilirken, SEVO grubu hastalarda sevofluran ile gerçekleştirildi. Hastaların demografik özellikleri, perioperatif verileri, kırmızı hücre dağılım genişliği (RDW) ve ortalama platelet volümü (MPV) değerleri kaydedildi. Bulgular: SEVO grubunda ekstübasyon zamanının kısa olması dışında, iki grup arasında perioperatif veriler açısından anlamlı fark görülmedi. Her iki grupta da RDW ve MPV değerlerinde postoperatif artış anlamlı bulundu. Postoperatif RDW değerindeki artışın SEVO grubunda daha düşük olduğu görüldü (p=0.013). Sonuç: Çalışmamızda, inflamasyon belirteci olan RDW’nin inhalasyon grubunda daha düşük olduğu bulundu. İnhalasyon ve TIVA anestezisi ile koroner arter cerrahisinde postoperatif komplikasyonlar ve mortalite açısından fark görülmedi

Effects of Intravenous Versus Inhalational Anesthesia on Red Cell Distribution Width and Mean Platelet Volume in Patients Undergoing Coronary Artery Surgery

Objective: The effects of midazolam-based intravenous anesthesia (TIVA) and sevoflurane-based inhalation anesthesia (SEVO) maintenance on postoperative hematological parameters were compared in patients undergoing coronary artery surgery. Methods: The 100 patients included in the study were divided into two groups according to the anesthesia management: All patients’ anesthesia inductions were performed with 10 μg kg-1 fentanyl, 0.15 mg kg-1 midazolam, and 0.8 mg kg-1 rocuronium. Anesthesia was maintained with total intravenous anesthesia in the TIVA group patients, while sevoflurane was used in the SEVO group patients. Demographic, clinical, operative data, red cell distribution width (RDW), and mean platelet volume (MPV) values were recorded. Results: Except that the extubation time was shorter in the SEVO group, no difference was observed between the groups in terms of all these variables. There was a significant increase in postoperative RDW and MPV measurements in both groups. Postoperative RDW value was lower in the inhalation anesthesia group compared to the TIVA group (p=0.013). Conclusion: In our study, RDW was found to be lower in the inhalation anesthesia group, indicating less inflammation. There was no difference in terms of postoperative complications and mortality

PDF

___

1. Aydınlı B, Demir A, Güçlü ÇY, et al. Hematological predictors and clinical outcomes in cardiac surgery. J Anesth. 2016;30:770-8. https://doi.org/10.1007/s00540-016-2197-y
2. Duchnowski P, Szymański P, Orłowska-Baranowska E, et al. Raised red cell distribution width as a prognostic marker in aortic valve replacement surgery. Kardiol Pol. 2016;74:547-52.
3. Tonelli M, Sacks F, Arnold M, et al. Relation between red blood cell distribution width and cardiovascular event rate in people with coronary disease. Circulation, 2008;117:163-8. https://doi.org/10.1161/CIRCULATIONAHA.107.727545
4. Ephrem G. Red blood cell distribution width is a predictor of readmission in cardiac patients. Clin Cardiol. 2013;36:293-9. https://doi.org/10.1002/clc.22116
5. Slavka G, Perkmann T, Haslacher H, et al. Mean platelet volume may represent a predictive parameter for overall vascular mortality and ischemic heart disease. Arterioscler Thromb Vasc Biol. 2011;31:1215-8. https://doi.org/10.1161/ATVBAHA.110.221788
6. Chu SG, Becker RC, Berger PB, et al. Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta-analysis. J Thromb Haemost. 2010;8:148-56. https://doi.org/10.1111/j.1538-7836.2009.03584.x
7. Minguet G, Joris J, Lamy M. Preconditioning and protection against ischaemia-reperfusion in non-cardiac organs: a place for volatile anaesthetics? Eur J Anaesthesiol. 2007;24:733-45. https://doi.org/10.1017/S0265021507000531
8. Landoni G, Rodseth RN, Santini F, et al. Randomized evidence for reduction of perioperative mortality. J Cardiothorac Vasc Anesth. 2012;26:764-72. https://doi.org/10.1053/j.jvca.2012.04.018
9. Gaya da Costa M, Kalmar AF, Struys MMRF. Inhaled Anesthetics: Environmental Role, Occupational Risk, and Clinical Use. J Clin Med. 2021;10:1306. https://doi.org/10.3390/jcm10061306
10. Engelman DT, Ben Ali W, Williams JB, et al. Guidelines for Perioperative Care in Cardiac Surgery: Enhanced Recovery After Surgery Society Recommendations. JAMA Surg. 2019;154:755-66. https://doi.org/10.1001/jamasurg.2019.1153
11. Lee YM, Song BC, Yeum KJ. Impact of Volatile Anesthetics on Oxidative Stress and Inflammation. Biomed Res Int. 2015;2015:242709 https://doi.org/10.1155/2015/242709
12. Schilling T, Kozian A, Senturk M, et al. Effects of volatile and intravenous anesthesia on the alveolar and systemic inflammatory response in thoracic surgical patients. Anesthesiology. 2011;115:65-74. https://doi.org/10.1097/ALN.0b013e318214b9de
13. Conno E, Steurer MP, Wittlinger M, et al. Anestheticinduced improvement of the inflammatory response to one-lung ventilation. Anesthesiology. 2009;110:1316- 26. https://doi.org/10.1097/ALN.0b013e3181a10731
14. Szyfter K, Szulc R, Mikstacki A, et al. Genotoxicity of inhalation anaesthetics: DNA lesions generated by sevoflurane in vitro and in vivo. J Appl Genet. 2004;45:369-74.
15. Tsuboi S, Miyauchi K, Kasai T, et al. Impact of red blood cell distribution width on long-term mortality in diabetic patients after percutaneous coronary intervention. Circ J. 2013;77:456-61. https://doi.org/10.1253/circj.CJ-12-0730
16. Tüysüz ME, Dedemoğlu M. High mean platelet volume to platelet count ratio as a predictor on poor outcomes after CABG. Gen Thorac Cardiovasc Surg. 2020;68:459- 66. https://doi.org/10.1007/s11748-019-01202-7
17. Unal EU, Ozen A, Kocabeyoğlu S, et al. Mean platelet volume may predict early clinical outcome after coronary artery bypass grafting. J Cardiothorac Surg. 2013;16:89-91. https://doi.org/10.1186/1749-8090-8-91
18. Erdem K, Ayhan S, Ozturk S, et al. Usefulness of the mean platelet volume for predicting new-onset atrial fibrillation after isolated coronary artery bypass grafting. Platelets. 2014;25:23-6. https://doi.org/10.3109/09537104.2013.767443